Skip to main content
Advertisement
Advertisement

ELAN

ELAN logo

Elanco Animal Health Incorporated Common Stock

22.14
USD
Sponsored
+0.37
+1.70%
Oct 02, 15:59 UTC -4
Closed
exchange

After-Market

22.14

0.00
-0.02%

ELAN Earnings Reports

Positive Surprise Ratio

ELAN beat 27 of 32 last estimates.

84%

Next Report

Date of Next Report
Nov 06, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.23B
/
$0.20
Implied change from Q2 26 (Revenue/ EPS)
-10.04%
/
-41.18%
Implied change from Q3 25 (Revenue/ EPS)
+8.23%
/
+5.26%

Elanco Animal Health Incorporated Common Stock earnings per share and revenue

On Aug 05, 2026, ELAN reported earnings of 0.34 USD per share (EPS) for Q2 26, beating the estimate of 0.27 USD, resulting in a 23.77% surprise. Revenue reached 1.37 billion, compared to an expected 1.34 billion, with a 2.18% difference. The market reacted with a +2.42% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 13 analysts forecast an EPS of 0.20 USD, with revenue projected to reach 1.23 billion USD, implying an decrease of -41.18% EPS, and decrease of -10.04% in Revenue from the last quarter.
FAQ
For Q2 2026, Elanco Animal Health Incorporated Common Stock reported EPS of $0.34, beating estimates by 23.77%, and revenue of $1.37B, 2.18% above expectations.
The stock price moved up 2.42%, changed from $25.60 before the earnings release to $26.22 the day after.
The next earning report is scheduled for Nov 06, 2026.
Based on 13 analysts, Elanco Animal Health Incorporated Common Stock is expected to report EPS of $0.20 and revenue of $1.23B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement